{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:48:30Z","timestamp":1794714510115,"version":"4.9.1"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41574-025-01132-w","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T09:54:15Z","timestamp":1749030855000},"page":"530-545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Diabetes mellitus polygenic risk scores: heterogeneity and clinical translation"],"prefix":"10.1038","volume":"21","author":[{"given":"Hector I.","family":"Ortega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam S.","family":"Udler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1205-1844","authenticated-orcid":false,"given":"Anna L.","family":"Gloyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0607-9990","authenticated-orcid":false,"given":"Seth A.","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"1132_CR1","unstructured":"International Diabetes Federation. in IDF Diabetes Atlas 11th edn (eds Maglianno, D. J. et al.) 6\u201321 (IDF, 2025)."},{"key":"1132_CR2","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1001\/jama.2021.11165","volume":"326","author":"JM Lawrence","year":"2021","unstructured":"Lawrence, J. M. et al. Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001\u20132017. JAMA 326, 717\u2013727 (2021).","journal-title":"JAMA"},{"key":"1132_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.15585\/mmwr.mm6712a2","volume":"67","author":"KM Bullard","year":"2018","unstructured":"Bullard, K. M. et al. Prevalence of diagnosed diabetes in adults by diabetes type \u2014 United States, 2016. MMWR Morbidity Mortal. Wkly Rep. 67, 359\u2013361 (2018).","journal-title":"MMWR Morbidity Mortal. Wkly Rep."},{"key":"1132_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.16","volume":"3","author":"A Katsarou","year":"2017","unstructured":"Katsarou, A. et al. Type 1 diabetes mellitus. Nat. Rev. Dis. Primers 3, 17016 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1132_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.19","volume":"1","author":"RA Defronzo","year":"2015","unstructured":"Defronzo, R. A. et al. Type 2 diabetes mellitus. Nat. Rev. Dis. Primers 1, 15019 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1132_CR6","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41591-022-01790-7","volume":"28","author":"ATN Nair","year":"2022","unstructured":"Nair, A. T. N. et al. Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes. Nat. Med. 28, 982\u2013988 (2022).","journal-title":"Nat. Med."},{"key":"1132_CR7","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1007\/s00125-022-05769-4","volume":"65","author":"AJ Deutsch","year":"2022","unstructured":"Deutsch, A. J., Ahlqvist, E. & Udler, M. S. Phenotypic and genetic classification of diabetes. Diabetologia 65, 1758\u20131769 (2022).","journal-title":"Diabetologia"},{"key":"1132_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s43856-023-00360-3","volume":"3","author":"S Misra","year":"2023","unstructured":"Misra, S. et al. Precision subclassification of type 2 diabetes: a systematic review. Commun. Med. 3, 138 (2023).","journal-title":"Commun. Med."},{"key":"1132_CR9","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41574-023-00853-0","volume":"19","author":"MJ Redondo","year":"2023","unstructured":"Redondo, M. J. & Morgan, N. G. Heterogeneity and endotypes in type 1 diabetes mellitus. Nat. Rev. Endocrinol. 19, 542\u2013554 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1132_CR10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41574-019-0254-y","volume":"15","author":"J Ilonen","year":"2019","unstructured":"Ilonen, J., Lempainen, J. & Veijola, R. The heterogeneous pathogenesis of type 1 diabetes mellitus. Nat. Rev. Endocrinol. 15, 635\u2013650 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1132_CR11","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","volume":"383","author":"SE Kahn","year":"2014","unstructured":"Kahn, S. E., Cooper, M. E. & Del Prato, S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383, 1068\u20131083 (2014).","journal-title":"Lancet"},{"key":"1132_CR12","unstructured":"Kreienkamp, R. J. et al. in Diabetes in America [Internet] (eds Lawrence, J. M. et al.) Section I, Ch. 2 (National Institute of Diabetes and Digestive and Kidney Diseases, 2023)."},{"key":"1132_CR13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142244","volume":"131","author":"H Zhang","year":"2021","unstructured":"Zhang, H., Colclough, K., Gloyn, A. L. & Pollin, T. I. Monogenic diabetes: a gateway to precision medicine in diabetes. J. Clin. Invest. 131, e142244 (2021).","journal-title":"J. Clin. Invest."},{"key":"1132_CR14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41588-021-00783-5","volume":"53","author":"SA Lambert","year":"2021","unstructured":"Lambert, S. A. et al. The polygenic score catalog as an open database for reproducibility and systematic evaluation. Nat. Genet. 53, 420\u2013425 (2021).","journal-title":"Nat. Genet."},{"key":"1132_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41576-018-0018-x","volume":"19","author":"A Torkamani","year":"2018","unstructured":"Torkamani, A., Wineinger, N. E. & Topol, E. J. The personal and clinical utility of polygenic risk scores. Nat. Rev. Genet. 19, 581\u2013590 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"1132_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00742-5","volume":"12","author":"CM Lewis","year":"2020","unstructured":"Lewis, C. M. & Vassos, E. Polygenic risk scores: from research tools to clinical instruments. Genome Med. 12, 44 (2020).","journal-title":"Genome Med."},{"key":"1132_CR17","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","volume":"50","author":"AV Khera","year":"2018","unstructured":"Khera, A. V. et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat. Genet. 50, 1219\u20131224 (2018).","journal-title":"Nat. Genet."},{"key":"1132_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s00125-022-05806-2","volume":"66","author":"LA Stalbow","year":"2023","unstructured":"Stalbow, L. A. et al. The contribution of functional HNF1A variants and polygenic susceptibility to risk of type 2 diabetes in ancestrally diverse populations. Diabetologia 66, 116\u2013126 (2023).","journal-title":"Diabetologia"},{"key":"1132_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17374-3","volume":"11","author":"AC Fahed","year":"2020","unstructured":"Fahed, A. C. et al. Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. Nat. Commun. 11, 3635 (2020).","journal-title":"Nat. Commun."},{"key":"1132_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23556-4","volume":"12","author":"JK Goodrich","year":"2021","unstructured":"Goodrich, J. K. et al. Determinants of penetrance and variable expressivity in monogenic metabolic conditions across 77,184 exomes. Nat. Commun. 12, 3505 (2021).","journal-title":"Nat. Commun."},{"key":"1132_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S2213-8587(23)00129-8","volume":"11","author":"S Hassan","year":"2023","unstructured":"Hassan, S. et al. Disparities in diabetes prevalence and management by race and ethnicity in the USA: defining a path forward. Lancet Diabetes Endocrinol. 11, 509\u2013524 (2023).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1132_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0140-6736(23)00909-1","volume":"402","author":"S Agarwal","year":"2023","unstructured":"Agarwal, S. et al. The role of structural racism and geographical inequity in diabetes outcomes. Lancet 402, 235\u2013249 (2023).","journal-title":"Lancet"},{"key":"1132_CR23","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1056\/NEJMc0805398","volume":"359","author":"MJ Redondo","year":"2008","unstructured":"Redondo, M. J., Jeffrey, J., Fain, P. R., Eisenbarth, G. S. & Orban, T. Concordance for islet autoimmunity among monozygotic twins. N. Engl. J. Med. 359, 2849\u20132850 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1132_CR24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S2213-8587(24)00068-8","volume":"12","author":"Y Wei","year":"2024","unstructured":"Wei, Y. et al. Familial aggregation and heritability of childhood-onset and adult-onset type 1 diabetes: a Swedish register-based cohort study. Lancet Diabetes Endocrinol. 12, 320\u2013329 (2024).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1132_CR25","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1017\/thg.2015.83","volume":"18","author":"G Willemsen","year":"2015","unstructured":"Willemsen, G. et al. The concordance and heritability of type 2 diabetes in 34,166 twin pairs from international twin registers: the discordant twin (DISCOTWIN) consortium. Twin Res. Hum. Genet. 18, 762\u2013771 (2015).","journal-title":"Twin Res. Hum. Genet."},{"key":"1132_CR26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41586-021-03552-w","volume":"594","author":"J Chiou","year":"2021","unstructured":"Chiou, J. et al. Interpreting type 1 diabetes risk with genetics and single-cell epigenomics. Nature 594, 398\u2013402 (2021).","journal-title":"Nature"},{"key":"1132_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41586-024-07019-6","volume":"627","author":"K Suzuki","year":"2024","unstructured":"Suzuki, K. et al. Genetic drivers of heterogeneity in type 2 diabetes pathophysiology. Nature 627, 347\u2013357 (2024).","journal-title":"Nature"},{"key":"1132_CR28","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1101\/gr.6665407","volume":"17","author":"NR Wray","year":"2007","unstructured":"Wray, N. R., Goddard, M. E. & Visscher, P. M. Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res. 17, 1520\u20131528 (2007).","journal-title":"Genome Res."},{"key":"1132_CR29","unstructured":"US Centers for Disease Control and Prevention. National Diabetes Statistics Report. CDC https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/index.html (2021)."},{"key":"1132_CR30","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"American Diabetes Association Professional Practice Committee.","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of care in diabetes \u2014 2024. Diabetes Care 47, S20\u2013S42 (2024).","journal-title":"Diabetes Care"},{"key":"1132_CR31","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1007\/s00125-021-05428-0","volume":"64","author":"JRJ Inshaw","year":"2021","unstructured":"Inshaw, J. R. J. et al. Analysis of overlapping genetic association in type 1 and type 2 diabetes. Diabetologia 64, 1342\u20131347 (2021).","journal-title":"Diabetologia"},{"key":"1132_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/MED.0000000000000548","volume":"27","author":"EK Sims","year":"2020","unstructured":"Sims, E. K., Mirmira, R. G. & Evans-Molina, C. The role of beta-cell dysfunction in early type 1 diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 27, 215\u2013224 (2020).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"1132_CR33","unstructured":"Redondo, M. J. et al. in Diabetes in America [Internet] (eds Lawrence, J. M. et al.) Section I, Ch. 1 (National Institute of Diabetes and Digestive and Kidney Diseases, 2023)."},{"key":"1132_CR34","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41588-020-0637-y","volume":"52","author":"M Vujkovic","year":"2020","unstructured":"Vujkovic, M. et al. Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat. Genet. 52, 680\u2013691 (2020).","journal-title":"Nat. Genet."},{"key":"1132_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48654-x","volume":"15","author":"R Ohta","year":"2024","unstructured":"Ohta, R., Tanigawa, Y., Suzuki, Y., Kellis, M. & Morishita, S. A polygenic score method boosted by non-additive models. Nat. Commun. 15, 4433 (2024).","journal-title":"Nat. Commun."},{"key":"1132_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13195-021-00794-8","volume":"13","author":"H Wang","year":"2021","unstructured":"Wang, H., Bennett, D. A., De Jager, P. L., Zhang, Q.-Y. & Zhang, H.-Y. Genome-wide epistasis analysis for Alzheimer\u2019s disease and implications for genetic risk prediction. Alzheimers Res. Ther. 13, 55 (2021).","journal-title":"Alzheimers Res. Ther."},{"key":"1132_CR37","doi-asserted-by":"publisher","first-page":"025056","DOI":"10.1088\/2057-1976\/adbb71","volume":"11","author":"S Squires","year":"2025","unstructured":"Squires, S., Weedon, M. N. & Oram, R. A. Exploring the application of deep learning methods for polygenic risk score estimation. Biomed. Phys. Eng. Express. 11, 025056 (2025).","journal-title":"Biomed. Phys. Eng. Express."},{"key":"1132_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2021.100086","volume":"2","author":"Y Xu","year":"2022","unstructured":"Xu, Y. et al. Machine learning optimized polygenic scores for blood cell traits identify sex-specific trajectories and genetic correlations with disease. Cell Genom. 2, 100086 (2022).","journal-title":"Cell Genom."},{"key":"1132_CR39","doi-asserted-by":"crossref","unstructured":"Li, H., Zeng, J., Snyder, M. P. & Zhang, S. in Research in Computational Molecular Biology. RECOMB 2024. Lecture Notes in Computer Science 14758 (ed. Ma, J.) 377\u2013380 (Springer, 2024).","DOI":"10.1007\/978-1-0716-3989-4_35"},{"key":"1132_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1469-1809.1980.tb00954.x","volume":"44","author":"RS Spielman","year":"1980","unstructured":"Spielman, R. S., Baker, L. & Zmijewski, C. M. Gene dosage and suceptibility to insulin-dependent diabetes. Ann. Hum. Genet. 44, 135\u2013150 (1980).","journal-title":"Ann. Hum. Genet."},{"key":"1132_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1399-0039.1982.tb01442.x","volume":"19","author":"A Green","year":"1982","unstructured":"Green, A. et al. Genetic studies of insulin\u2010dependent diabetes mellitus: segregation and linkage analyses. Tissue Antigens 19, 213\u2013221 (1982).","journal-title":"Tissue Antigens"},{"key":"1132_CR42","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1007\/s00125-021-05513-4","volume":"64","author":"NJ Thomas","year":"2021","unstructured":"Thomas, N. J. et al. DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life. Diabetologia 64, 2258\u20132265 (2021).","journal-title":"Diabetologia"},{"key":"1132_CR43","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1172\/JCI111441","volume":"74","author":"D Raum","year":"1984","unstructured":"Raum, D., Awdeh, Z., Yunis, E. J., Alper, C. A. & Gabbay, K. H. Extended major histocompatibility complex haplotypes in type I diabetes mellitus. J. Clin. Invest. 74, 449\u2013454 (1984).","journal-title":"J. Clin. Invest."},{"key":"1132_CR44","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/apt.15826","volume":"52","author":"SA Sharp","year":"2020","unstructured":"Sharp, S. A. et al. A single nucleotide polymorphism genetic risk score to aid diagnosis of coeliac disease: a pilot study in clinical care. Aliment. Pharmacol. Ther. 52, 1165\u20131173 (2020).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"1132_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104581","volume":"92","author":"HG Zhang","year":"2023","unstructured":"Zhang, H. G. et al. Identifying shared genetic architecture between rheumatoid arthritis and other conditions: a phenome-wide association study with genetic risk scores. eBioMedicine 92, 104581 (2023).","journal-title":"eBioMedicine"},{"key":"1132_CR46","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.trim.2005.03.021","volume":"14","author":"E Thorsby","year":"2005","unstructured":"Thorsby, E. & Lie, B. A. HLA associated genetic predisposition to autoimmune diseases: genes involved and possible mechanisms. Transpl. Immunol. 14, 175\u2013182 (2005).","journal-title":"Transpl. Immunol."},{"key":"1132_CR47","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.2337\/db08-1551","volume":"58","author":"P Concannon","year":"2009","unstructured":"Concannon, P. et al. Genome-wide scan for linkage to type 1 diabetes in 2,496 multiplex families from the type 1 diabetes genetics consortium. Diabetes 58, 1018\u20131022 (2009).","journal-title":"Diabetes"},{"key":"1132_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1375.001","volume":"1079","author":"SS Rich","year":"2006","unstructured":"Rich, S. S. et al. The Type 1 Diabetes Genetics Consortium. Ann. N. Y. Acad. Sci. 1079, 1\u20138 (2006).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1132_CR49","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41588-021-00880-5","volume":"53","author":"CC Robertson","year":"2021","unstructured":"Robertson, C. C. et al. Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes. Nat. Genet. 53, 962\u2013971 (2021).","journal-title":"Nat. Genet."},{"key":"1132_CR50","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05911","volume":"447","author":"The Wellcome Trust Case Control Consortium.","year":"2007","unstructured":"The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661\u2013678 (2007).","journal-title":"Nature"},{"key":"1132_CR51","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/ng.381","volume":"41","author":"JC Barrett","year":"2009","unstructured":"Barrett, J. C. et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat. Genet. 41, 703\u2013707 (2009).","journal-title":"Nat. Genet."},{"key":"1132_CR52","doi-asserted-by":"publisher","first-page":"662","DOI":"10.2337\/diacare.29.03.06.dc05-0774","volume":"29","author":"S Mrena","year":"2006","unstructured":"Mrena, S. et al. Models for predicting type 1 diabetes in siblings of affected children. Diabetes Care 29, 662\u2013667 (2006).","journal-title":"Diabetes Care"},{"key":"1132_CR53","doi-asserted-by":"publisher","first-page":"14074","DOI":"10.1073\/pnas.0606349103","volume":"103","author":"TA Aly","year":"2006","unstructured":"Aly, T. A. et al. Extreme genetic risk for type 1A diabetes. Proc. Natl Acad. Sci. USA 103, 14074\u201314079 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1132_CR54","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/dmrr.1234","volume":"27","author":"H Yamashita","year":"2011","unstructured":"Yamashita, H. et al. Analysis of the HLA and non\u2010HLA susceptibility loci in Japanese type 1 diabetes. Diabetes Metab. Res. Rev. 27, 844\u2013848 (2011).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"1132_CR55","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.2337\/db11-0364","volume":"60","author":"JM Howson","year":"2011","unstructured":"Howson, J. M., Rosinger, S., Smyth, D. J., Boehm, B. O. & Todd, J. A. Genetic analysis of adult-onset autoimmune diabetes. Diabetes 60, 2645\u20132653 (2011).","journal-title":"Diabetes"},{"key":"1132_CR56","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1007\/s00125-014-3362-1","volume":"57","author":"C Winkler","year":"2014","unstructured":"Winkler, C. et al. Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes. Diabetologia 57, 2521\u20132529 (2014).","journal-title":"Diabetologia"},{"key":"1132_CR57","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2337\/dc15-1111","volume":"39","author":"RA Oram","year":"2016","unstructured":"Oram, R. A. et al. A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults. Diabetes Care 39, 337\u2013344 (2016).","journal-title":"Diabetes Care"},{"key":"1132_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002548","volume":"15","author":"E Bonifacio","year":"2018","unstructured":"Bonifacio, E. et al. Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: a prospective study in children. PLoS Med. 15, e1002548 (2018).","journal-title":"PLoS Med."},{"key":"1132_CR59","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2337\/dc18-1785","volume":"42","author":"SA Sharp","year":"2019","unstructured":"Sharp, S. A. et al. Development and standardization of an improved type 1 diabetes genetic risk score for use in newborn screening and incident diagnosis. Diabetes Care 42, 200\u2013207 (2019).","journal-title":"Diabetes Care"},{"key":"1132_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064683","volume":"8","author":"X Jia","year":"2013","unstructured":"Jia, X. et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS ONE 8, e64683 (2013).","journal-title":"PLoS ONE"},{"key":"1132_CR61","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/pedi.13310","volume":"23","author":"HQ Qu","year":"2022","unstructured":"Qu, H. Q. et al. Improved genetic risk scoring algorithm for type 1 diabetes prediction. Pediatr. Diabetes 23, 320\u2013323 (2022).","journal-title":"Pediatr. Diabetes"},{"key":"1132_CR62","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5808\/GI.2012.10.2.117","volume":"10","author":"EP Hong","year":"2012","unstructured":"Hong, E. P. & Park, J. W. Sample size and statistical power calculation in genetic association studies. Genomics Inform. 10, 117\u2013122 (2012).","journal-title":"Genomics Inform."},{"key":"1132_CR63","doi-asserted-by":"publisher","unstructured":"McGrail, C., Sears, T. J., Kudtarkar, P., Carter, H. & Gaulton, K. Genetic association and machine learning improves discovery and prediction of type 1 diabetes. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2024.07.31.24311310 (2024).","DOI":"10.1101\/2024.07.31.24311310"},{"key":"1132_CR64","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11892-011-0223-x","volume":"11","author":"JA Noble","year":"2011","unstructured":"Noble, J. A. & Valdes, A. M. Genetics of the HLA region in the prediction of type 1 diabetes. Curr. Diab. Rep. 11, 533\u2013542 (2011).","journal-title":"Curr. Diab. Rep."},{"key":"1132_CR65","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.2337\/db20-0224","volume":"69","author":"A Nag","year":"2020","unstructured":"Nag, A., Mccarthy, M. I. & Mahajan, A. Large-scale analyses provide no evidence for gene-gene interactions influencing type 2 diabetes risk. Diabetes 69, 2518\u20132522 (2020).","journal-title":"Diabetes"},{"key":"1132_CR66","doi-asserted-by":"publisher","first-page":"568","DOI":"10.2337\/diabetes.52.2.568","volume":"52","author":"AL Gloyn","year":"2003","unstructured":"Gloyn, A. L. et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52, 568\u2013572 (2003).","journal-title":"Diabetes"},{"key":"1132_CR67","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/79216","volume":"26","author":"D Altshuler","year":"2000","unstructured":"Altshuler, D. et al. The common PPAR\u03b3 Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26, 76\u201380 (2000).","journal-title":"Nat. Genet."},{"key":"1132_CR68","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nature05616","volume":"445","author":"R Sladek","year":"2007","unstructured":"Sladek, R. et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445, 881\u2013885 (2007).","journal-title":"Nature"},{"key":"1132_CR69","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1126\/science.1142358","volume":"316","author":"R Saxena","year":"2007","unstructured":"Saxena, R. et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316, 1331\u20131336 (2007).","journal-title":"Science"},{"key":"1132_CR70","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1126\/science.1142364","volume":"316","author":"E Zeggini","year":"2007","unstructured":"Zeggini, E. et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316, 1336\u20131341 (2007).","journal-title":"Science"},{"key":"1132_CR71","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/ng2043","volume":"39","author":"V Steinthorsdottir","year":"2007","unstructured":"Steinthorsdottir, V. et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat. Genet. 39, 770\u2013775 (2007).","journal-title":"Nat. Genet."},{"key":"1132_CR72","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1126\/science.1142382","volume":"316","author":"LJ Scott","year":"2007","unstructured":"Scott, L. J. et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341\u20131345 (2007).","journal-title":"Science"},{"key":"1132_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030374","volume":"3","author":"MN Weedon","year":"2006","unstructured":"Weedon, M. N. et al. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med. 3, e374 (2006).","journal-title":"PLoS Med."},{"key":"1132_CR74","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.2337\/db08-0504","volume":"57","author":"H Lango","year":"2008","unstructured":"Lango, H. et al. Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes 57, 3129\u20133135 (2008).","journal-title":"Diabetes"},{"key":"1132_CR75","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1056\/NEJMoa0804742","volume":"359","author":"JB Meigs","year":"2008","unstructured":"Meigs, J. B. et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N. Engl. J. Med. 359, 2208\u20132219 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1132_CR76","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMoa0801869","volume":"359","author":"V Lyssenko","year":"2008","unstructured":"Lyssenko, V. et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N. Engl. J. Med. 359, 2220\u20132232 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1132_CR77","doi-asserted-by":"publisher","first-page":"541","DOI":"10.7326\/0003-4819-150-8-200904210-00008","volume":"150","author":"MC Cornelis","year":"2009","unstructured":"Cornelis, M. C. et al. Joint effects of common genetic variants on the risk for type 2 diabetes in US men and women of European ancestry. Ann. Intern. Med. 150, 541\u2013550 (2009).","journal-title":"Ann. Intern. Med."},{"key":"1132_CR78","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2337\/dc10-1265","volume":"34","author":"JM de Miguel-Yanes","year":"2011","unstructured":"de Miguel-Yanes, J. M. et al. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care 34, 121\u2013125 (2011).","journal-title":"Diabetes Care"},{"key":"1132_CR79","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.2337\/db13-1663","volume":"63","author":"JL Vassy","year":"2014","unstructured":"Vassy, J. L. et al. Polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes 63, 2172\u20132182 (2014).","journal-title":"Diabetes"},{"key":"1132_CR80","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41588-018-0241-6","volume":"50","author":"A Mahajan","year":"2018","unstructured":"Mahajan, A. et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat. Genet. 50, 1505\u20131513 (2018).","journal-title":"Nat. Genet."},{"key":"1132_CR81","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ng.609","volume":"42","author":"BF Voight","year":"2010","unstructured":"Voight, B. F. et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 42, 579\u2013589 (2010).","journal-title":"Nat. Genet."},{"key":"1132_CR82","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ng.2383","volume":"44","author":"AP Morris","year":"2012","unstructured":"Morris, A. P. et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 44, 981\u2013990 (2012).","journal-title":"Nat. Genet."},{"key":"1132_CR83","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.2337\/db16-1253","volume":"66","author":"RA Scott","year":"2017","unstructured":"Scott, R. A. et al. An expanded genome-wide association study of type 2 diabetes in Europeans. Diabetes 66, 2888\u20132902 (2017).","journal-title":"Diabetes"},{"key":"1132_CR84","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41588-022-01058-3","volume":"54","author":"A Mahajan","year":"2022","unstructured":"Mahajan, A. et al. Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nat. Genet. 54, 560\u2013572 (2022).","journal-title":"Nat. Genet."},{"key":"1132_CR85","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41588-022-01054-7","volume":"54","author":"Y Ruan","year":"2022","unstructured":"Ruan, Y. et al. Improving polygenic prediction in ancestrally diverse populations. Nat. Genet. 54, 573\u2013580 (2022).","journal-title":"Nat. Genet."},{"key":"1132_CR86","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00125-023-05912-9","volume":"66","author":"A Huerta-Chagoya","year":"2023","unstructured":"Huerta-Chagoya, A. et al. The power of TOPMed imputation for the discovery of Latino-enriched rare variants associated with type 2 diabetes. Diabetologia 66, 1273\u20131288 (2023).","journal-title":"Diabetologia"},{"key":"1132_CR87","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41586-022-05275-y","volume":"610","author":"L Yengo","year":"2022","unstructured":"Yengo, L. et al. A saturated map of common genetic variants associated with human height. Nature 610, 704\u2013712 (2022).","journal-title":"Nature"},{"key":"1132_CR88","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nature08494","volume":"461","author":"TA Manolio","year":"2009","unstructured":"Manolio, T. A. et al. Finding the missing heritability of complex diseases. Nature 461, 747\u2013753 (2009).","journal-title":"Nature"},{"key":"1132_CR89","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-019-1231-2","volume":"570","author":"J Flannick","year":"2019","unstructured":"Flannick, J. et al. Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature 570, 71\u201376 (2019).","journal-title":"Nature"},{"key":"1132_CR90","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1038\/s41588-024-01947-9","volume":"56","author":"A Huerta-Chagoya","year":"2024","unstructured":"Huerta-Chagoya, A. et al. Rare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genes. Nat. Genet. 56, 2370\u20132379 (2024).","journal-title":"Nat. Genet."},{"key":"1132_CR91","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1007\/s00125-021-05490-8","volume":"64","author":"RC Slieker","year":"2021","unstructured":"Slieker, R. C. et al. Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study. Diabetologia 64, 1982\u20131989 (2021).","journal-title":"Diabetologia"},{"key":"1132_CR92","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist, E. et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 6, 361\u2013369 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1132_CR93","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41591-020-1116-9","volume":"27","author":"R Wagner","year":"2021","unstructured":"Wagner, R. et al. Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes. Nat. Med. 27, 49\u201357 (2021).","journal-title":"Nat. Med."},{"key":"1132_CR94","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S2213-8587(19)30087-7","volume":"7","author":"JM Dennis","year":"2019","unstructured":"Dennis, J. M., Shields, B. M., Henley, W. E., Jones, A. G. & Hattersley, A. T. Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol. 7, 442\u2013451 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1132_CR95","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00125-017-4210-x","volume":"60","author":"MI McCarthy","year":"2017","unstructured":"McCarthy, M. I. Painting a new picture of personalised medicine for diabetes. Diabetologia 60, 793\u2013799 (2017).","journal-title":"Diabetologia"},{"key":"1132_CR96","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/ng.520","volume":"42","author":"J Dupuis","year":"2010","unstructured":"Dupuis, J. et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 42, 105\u2013116 (2010).","journal-title":"Nat. Genet."},{"key":"1132_CR97","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/ng.2274","volume":"44","author":"AK Manning","year":"2012","unstructured":"Manning, A. K. et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat. Genet. 44, 659\u2013669 (2012).","journal-title":"Nat. Genet."},{"key":"1132_CR98","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nature11401","volume":"490","author":"J Yang","year":"2012","unstructured":"Yang, J. et al. FTO genotype is associated with phenotypic variability of body mass index. Nature 490, 267\u2013272 (2012).","journal-title":"Nature"},{"key":"1132_CR99","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1093\/hmg\/ddy271","volume":"27","author":"L Yengo","year":"2018","unstructured":"Yengo, L. et al. Meta-analysis of genome-wide association studies for height and body mass index in ~700000 individuals of European ancestry. Hum. Mol. Genet. 27, 3641\u20133649 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"1132_CR100","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41588-023-01462-3","volume":"55","author":"V Lagou","year":"2023","unstructured":"Lagou, V. et al. GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification. Nat. Genet. 55, 1448\u20131461 (2023).","journal-title":"Nat. Genet."},{"key":"1132_CR101","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.2337\/db13-0949","volume":"63","author":"AS Dimas","year":"2014","unstructured":"Dimas, A. S. et al. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 63, 2158\u20132171 (2014).","journal-title":"Diabetes"},{"key":"1132_CR102","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41588-021-00852-9","volume":"53","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. The trans-ancestral genomic architecture of glycemic traits. Nat. Genet. 53, 840\u2013860 (2021).","journal-title":"Nat. Genet."},{"key":"1132_CR103","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ajhg.2023.01.002","volume":"110","author":"KA Broadaway","year":"2023","unstructured":"Broadaway, K. A. et al. Loci for insulin processing and secretion provide insight into type 2 diabetes risk. Am. J. Hum. Genet. 110, 284\u2013299 (2023).","journal-title":"Am. J. Hum. Genet."},{"key":"1132_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02837-1","volume":"23","author":"S Kanoni","year":"2022","unstructured":"Kanoni, S. et al. Implicating genes, pleiotropy, and sexual dimorphism at blood lipid loci through multi-ancestry meta-analysis. Genome Biol. 23, 268 (2022).","journal-title":"Genome Biol."},{"key":"1132_CR105","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41586-021-04064-3","volume":"600","author":"SE Graham","year":"2021","unstructured":"Graham, S. E. et al. The power of genetic diversity in genome-wide association studies of lipids. Nature 600, 675\u2013679 (2021).","journal-title":"Nature"},{"key":"1132_CR106","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.ajhg.2022.06.012","volume":"109","author":"S Ramdas","year":"2022","unstructured":"Ramdas, S. et al. A multi-layer functional genomic analysis to understand noncoding genetic variation in lipids. Am. J. Hum. Genet. 109, 1366\u20131387 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"1132_CR107","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.2337\/db14-0318","volume":"63","author":"H Yaghootkar","year":"2014","unstructured":"Yaghootkar, H. et al. Genetic evidence for a normal-weight \u201cmetabolically obese\u201d phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes. Diabetes 63, 4369\u20134377 (2014).","journal-title":"Diabetes"},{"key":"1132_CR108","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.ajhg.2020.10.009","volume":"107","author":"JM Torres","year":"2020","unstructured":"Torres, J. M. et al. A multi-omic integrative scheme characterizes tissues of action at loci associated with type 2 diabetes. Am. J. Hum. Genet. 107, 1011\u20131028 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"1132_CR109","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.2337\/dc17-0290","volume":"40","author":"C Cropano","year":"2017","unstructured":"Cropano, C. et al. The rs7903146 variant in the TCF7L2 gene increases the risk of prediabetes\/type 2 diabetes in obese adolescents by impairing \u03b2-cell function and hepatic insulin sensitivity. Diabetes Care 40, 1082\u20131089 (2017).","journal-title":"Diabetes Care"},{"key":"1132_CR110","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1093\/hmg\/ddu359","volume":"23","author":"Y Zhou","year":"2014","unstructured":"Zhou, Y. et al. TCF7L2 is a master regulator of insulin production and processing. Hum. Mol. Genet. 23, 6419\u20136431 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"1132_CR111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002654","volume":"15","author":"MS Udler","year":"2018","unstructured":"Udler, M. S. et al. Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: a soft clustering analysis. PLoS Med. 15, e1002654 (2018).","journal-title":"PLoS Med."},{"key":"1132_CR112","doi-asserted-by":"publisher","first-page":"674","DOI":"10.2337\/dc21-1395","volume":"45","author":"D DiCorpo","year":"2022","unstructured":"DiCorpo, D. et al. Type 2 diabetes partitioned polygenic scores associate with disease outcomes in 454,193 individuals across 13 cohorts. Diabetes Care 45, 674\u2013683 (2022).","journal-title":"Diabetes Care"},{"key":"1132_CR113","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00125-022-05848-6","volume":"66","author":"H Kim","year":"2023","unstructured":"Kim, H. et al. High-throughput genetic clustering of type 2 diabetes loci reveals heterogeneous mechanistic pathways of metabolic disease. Diabetologia 66, 495\u2013507 (2023).","journal-title":"Diabetologia"},{"key":"1132_CR114","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41591-024-02865-3","volume":"30","author":"K Smith","year":"2024","unstructured":"Smith, K. et al. Multi-ancestry polygenic mechanisms of type 2 diabetes. Nat. Med. 30, 1065\u20131074 (2024).","journal-title":"Nat. Med."},{"key":"1132_CR115","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s00125-023-05955-y","volume":"66","author":"AM Luckett","year":"2023","unstructured":"Luckett, A. M. et al. Utility of genetic risk scores in type 1 diabetes. Diabetologia 66, 1589\u20131600 (2023).","journal-title":"Diabetologia"},{"key":"1132_CR116","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1001\/jama.2013.6285","volume":"309","author":"AG Ziegler","year":"2013","unstructured":"Ziegler, A. G. et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309, 2473\u20132479 (2013).","journal-title":"JAMA"},{"key":"1132_CR117","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2337\/dc10-2088","volume":"34","author":"AK Steck","year":"2011","unstructured":"Steck, A. K. et al. Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young. Diabetes Care 34, 1397\u20131399 (2011).","journal-title":"Diabetes Care"},{"key":"1132_CR118","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s43856-024-00478-y","volume":"4","author":"JL Felton","year":"2024","unstructured":"Felton, J. L. et al. Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review. Commun. Med. 4, 66 (2024).","journal-title":"Commun. Med."},{"key":"1132_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2022.100214","volume":"2","author":"P Benaglio","year":"2022","unstructured":"Benaglio, P. et al. Type 1 diabetes risk genes mediate pancreatic beta cell survival in response to proinflammatory cytokines. Cell Genom. 2, 100214 (2022).","journal-title":"Cell Genom."},{"key":"1132_CR120","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00125-020-05115-6","volume":"63","author":"P Leete","year":"2020","unstructured":"Leete, P. et al. Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis. Diabetologia 63, 1258\u20131267 (2020).","journal-title":"Diabetologia"},{"key":"1132_CR121","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/dc19-0880","volume":"43","author":"M Battaglia","year":"2020","unstructured":"Battaglia, M. et al. Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes. Diabetes Care 43, 5\u201312 (2020).","journal-title":"Diabetes Care"},{"key":"1132_CR122","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.gde.2018.03.009","volume":"50","author":"SA Sharp","year":"2018","unstructured":"Sharp, S. A., Weedon, M. N., Hagopian, W. A. & Oram, R. A. Clinical and research uses of genetic risk scores in type 1 diabetes. Curr. Opin. Genet. Dev. 50, 96\u2013102 (2018).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"1132_CR123","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","volume":"2","author":"E Sanderson","year":"2022","unstructured":"Sanderson, E. et al. Mendelian randomization. Nat. Rev. Methods Primers 2, 6 (2022).","journal-title":"Nat. Rev. Methods Primers"},{"key":"1132_CR124","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.ajhg.2019.09.001","volume":"105","author":"CK Raulerson","year":"2019","unstructured":"Raulerson, C. K. et al. Adipose tissue gene expression associations reveal hundreds of candidate genes for cardiometabolic traits. Am. J. Hum. Genet. 105, 773\u2013787 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"1132_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18581-8","volume":"11","author":"A Vi\u00f1uela","year":"2020","unstructured":"Vi\u00f1uela, A. et al. Genetic variant effects on gene expression in human pancreatic islets and their implications for T2D. Nat. Commun. 11, 4912 (2020).","journal-title":"Nat. Commun."},{"key":"1132_CR126","first-page":"165","volume":"8","author":"JM Torres","year":"2023","unstructured":"Torres, J. M. et al. Inferring causal genes at type 2 diabetes GWAS loci through chromosome interactions in islet cells. Wellcome Open. Res. 8, 165 (2023).","journal-title":"Wellcome Open. Res."},{"key":"1132_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09975-4","volume":"10","author":"WW Greenwald","year":"2019","unstructured":"Greenwald, W. W. et al. Pancreatic islet chromatin accessibility and conformation reveals distal enhancer networks of type 2 diabetes risk. Nat. Commun. 10, 2078 (2019).","journal-title":"Nat. Commun."},{"key":"1132_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109807","volume":"37","author":"L Alonso","year":"2021","unstructured":"Alonso, L. et al. TIGER: the gene expression regulatory variation landscape of human pancreatic islets. Cell Rep. 37, 109807 (2021).","journal-title":"Cell Rep."},{"key":"1132_CR129","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.ajhg.2021.05.001","volume":"108","author":"KW Currin","year":"2021","unstructured":"Currin, K. W. et al. Genetic effects on liver chromatin accessibility identify disease regulatory variants. Am. J. Hum. Genet. 108, 1169\u20131189 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"1132_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16537-6","volume":"11","author":"K Williams","year":"2020","unstructured":"Williams, K. et al. Skeletal muscle enhancer interactions identify genes controlling whole-body metabolism. Nat. Commun. 11, 2695 (2020).","journal-title":"Nat. Commun."},{"key":"1132_CR131","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.cmet.2022.08.014","volume":"34","author":"C Su","year":"2022","unstructured":"Su, C. et al. 3D chromatin maps of the human pancreas reveal lineage-specific regulatory architecture of T2D risk. Cell Metab. 34, 1394\u20131409.e1394 (2022).","journal-title":"Cell Metab."},{"key":"1132_CR132","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41588-024-01982-6","volume":"57","author":"SM Brotman","year":"2025","unstructured":"Brotman, S. M. et al. Adipose tissue eQTL meta-analysis highlights the contribution of allelic heterogeneity to gene expression regulation and cardiometabolic traits. Nat. Genet. 57, 180\u2013192 (2025).","journal-title":"Nat. Genet."},{"key":"1132_CR133","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1056\/NEJMoa1502214","volume":"373","author":"M Claussnitzer","year":"2015","unstructured":"Claussnitzer, M. et al. FTO obesity variant circuitry and adipocyte browning in humans. N. Engl. J. Med. 373, 895\u2013907 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1132_CR134","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41586-024-07510-0","volume":"633","author":"IGVF Consortium.","year":"2024","unstructured":"IGVF Consortium. Deciphering the impact of genomic variation on function. Nature 633, 47\u201357 (2024).","journal-title":"Nature"},{"key":"1132_CR135","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1126\/science.abi8207","volume":"373","author":"T Lappalainen","year":"2021","unstructured":"Lappalainen, T. & MacArthur, D. G. From variant to function in human disease genetics. Science 373, 1464\u20131468 (2021).","journal-title":"Science"},{"key":"1132_CR136","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/ng.3437","volume":"47","author":"KJ Gaulton","year":"2015","unstructured":"Gaulton, K. J. et al. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat. Genet. 47, 1415\u20131425 (2015).","journal-title":"Nat. Genet."},{"key":"1132_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41860-z","volume":"14","author":"HH Lau","year":"2023","unstructured":"Lau, H. H. et al. PAX4 loss of function increases diabetes risk by altering human pancreatic endocrine cell development. Nat. Commun. 14, 6119 (2023).","journal-title":"Nat. Commun."},{"key":"1132_CR138","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41586-023-06693-2","volume":"624","author":"JT Walker","year":"2023","unstructured":"Walker, J. T. et al. Genetic risk converges on regulatory networks mediating early type 2 diabetes. Nature 624, 621\u2013629 (2023).","journal-title":"Nature"},{"key":"1132_CR139","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"AE Carpenter","year":"2006","unstructured":"Carpenter, A. E. et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100 (2006).","journal-title":"Genome Biol."},{"key":"1132_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2023.100346","volume":"3","author":"S Laber","year":"2023","unstructured":"Laber, S. et al. Discovering cellular programs of intrinsic and extrinsic drivers of metabolic traits using LipocyteProfiler. Cell Genom. 3, 100346 (2023).","journal-title":"Cell Genom."},{"key":"1132_CR141","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/dmrr.2316","volume":"28","author":"M Campbell\u2010Thompson","year":"2012","unstructured":"Campbell\u2010Thompson, M. et al. Network for pancreatic organ donors with diabetes (nPOD): developing a tissue biobank for type 1 diabetes. Diabetes Metab. Res. Rev. 28, 608\u2013617 (2012).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"1132_CR142","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1007\/s00125-019-4876-3","volume":"62","author":"M Brissova","year":"2019","unstructured":"Brissova, M. et al. The integrated islet distribution program answers the call for improved human islet phenotyping and reporting of human islet characteristics in research articles. Diabetologia 62, 1312\u20131314 (2019).","journal-title":"Diabetologia"},{"key":"1132_CR143","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2337\/db19-0058","volume":"68","author":"KH Kaestner","year":"2019","unstructured":"Kaestner, K. H., Powers, A. C., Naji, A., HPAP Consortium & Atkinson, M. A. NIH initiative to improve understanding of the pancreas, islet, and autoimmunity in type 1 diabetes: the human pancreas analysis program (HPAP). Diabetes 68, 1394\u20131402 (2019).","journal-title":"Diabetes"},{"key":"1132_CR144","doi-asserted-by":"publisher","unstructured":"Evans-Molina, C. et al. Heterogeneous endocrine cell composition defines human islet functional phenotypes. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.11.20.623809 (2024).","DOI":"10.1101\/2024.11.20.623809"},{"key":"1132_CR145","doi-asserted-by":"publisher","unstructured":"Golden, G. J. et al. Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onset. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.04.23.590798 (2024).","DOI":"10.1101\/2024.04.23.590798"},{"key":"1132_CR146","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"1132_CR147","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508\u2013518 (2023).","journal-title":"Nature"},{"key":"1132_CR148","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1056\/NEJMsr1809937","volume":"381","author":"JC Denny","year":"2019","unstructured":"Denny, J. C. et al. The \u201cAll of Us\u201d research program. N. Engl. J. Med. 381, 668\u2013676 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1132_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26501-7","volume":"12","author":"BD Evans","year":"2021","unstructured":"Evans, B. D. et al. Estimating disease prevalence in large datasets using genetic risk scores. Nat. Commun. 12, 6441 (2021).","journal-title":"Nat. Commun."},{"key":"1132_CR150","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","volume":"6","author":"NJ Thomas","year":"2018","unstructured":"Thomas, N. J. et al. Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol. 6, 122\u2013129 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1132_CR151","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jclinepi.2022.10.022","volume":"153","author":"NJ Thomas","year":"2023","unstructured":"Thomas, N. J. et al. Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches. J. Clin. Epidemiol. 153, 34\u201344 (2023).","journal-title":"J. Clin. Epidemiol."},{"key":"1132_CR152","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2337\/dc17-0806","volume":"41","author":"PJ Bingley","year":"2018","unstructured":"Bingley, P. J. et al. Type 1 diabetes TrialNet: a multifaceted approach to bringing disease-modifying therapy to clinical use in type 1 diabetes. Diabetes Care 41, 653\u2013661 (2018).","journal-title":"Diabetes Care"},{"key":"1132_CR153","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2337\/dc18-0087","volume":"41","author":"MJ Redondo","year":"2018","unstructured":"Redondo, M. J. et al. A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk. Diabetes Care 41, 1887\u20131894 (2018).","journal-title":"Diabetes Care"},{"key":"1132_CR154","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1136\/jmedgenet-2018-105532","volume":"56","author":"A Beyerlein","year":"2019","unstructured":"Beyerlein, A. et al. Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: results from the prospective TEDDY study. J. Med. Genet. 56, 602\u2013605 (2019).","journal-title":"J. Med. Genet."},{"key":"1132_CR155","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.2337\/db10-1119","volume":"60","author":"MF Hivert","year":"2011","unstructured":"Hivert, M. F. et al. Updated genetic score based on 34 confirmed type 2 diabetes loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes 60, 1340\u20131348 (2011).","journal-title":"Diabetes"},{"key":"1132_CR156","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.2337\/db23-0761","volume":"73","author":"LK Billings","year":"2024","unstructured":"Billings, L. K. et al. Increased genetic risk for \u03b2-cell failure is associated with \u03b2-cell function decline in people with prediabetes. Diabetes 73, 1352\u20131360 (2024).","journal-title":"Diabetes"},{"key":"1132_CR157","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.2337\/dc21-0464","volume":"44","author":"MA Stanislawski","year":"2021","unstructured":"Stanislawski, M. A. et al. Genetic risk score for type 2 diabetes and traits related to glucose\u2013insulin homeostasis in youth: the Exploring Perinatal Outcomes among Children (EPOCH) Study. Diabetes Care 44, 2018\u20132024 (2021).","journal-title":"Diabetes Care"},{"key":"1132_CR158","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1007\/s00125-020-05276-4","volume":"63","author":"MB Johnson","year":"2020","unstructured":"Johnson, M. B. et al. Type 1 diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta cells. Diabetologia 63, 2605\u20132615 (2020).","journal-title":"Diabetologia"},{"key":"1132_CR159","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s00125-022-05806-2","volume":"66","author":"LA Stalbow","year":"2022","unstructured":"Stalbow, L. A. et al. The contribution of functional HNF1A variants and polygenic susceptibility to risk of type 2 diabetes in ancestrally diverse populations. Diabetologia 66, 116\u2013126 (2022).","journal-title":"Diabetologia"},{"key":"1132_CR160","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.2337\/dbi20-0017","volume":"69","author":"R Buzzetti","year":"2020","unstructured":"Buzzetti, R. et al. Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel. Diabetes 69, 2037\u20132047 (2020).","journal-title":"Diabetes"},{"key":"1132_CR161","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2337\/dc19-0986","volume":"43","author":"R Mishra","year":"2020","unstructured":"Mishra, R. et al. Genetic discrimination between LADA and childhood-onset type 1 diabetes within the MHC. Diabetes Care 43, 418\u2013425 (2020).","journal-title":"Diabetes Care"},{"key":"1132_CR162","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.2337\/dc23-0622","volume":"46","author":"D Osafehinti","year":"2023","unstructured":"Osafehinti, D. et al. Type 1 diabetes genetic risk score differentiates subgroups of ketosis-prone diabetes. Diabetes Care 46, 1778\u20131782 (2023).","journal-title":"Diabetes Care"},{"key":"1132_CR163","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00829-7","volume":"13","author":"ACF Lewis","year":"2021","unstructured":"Lewis, A. C. F. & Green, R. C. Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues. Genome Med. 13, 14 (2021).","journal-title":"Genome Med."},{"key":"1132_CR164","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2337\/dci22-0046","volume":"46","author":"W Perng","year":"2023","unstructured":"Perng, W., Conway, R., Mayer-Davis, E. & Dabelea, D. Youth-onset type 2 diabetes: the epidemiology of an awakening epidemic. Diabetes Care 46, 490\u2013499 (2023).","journal-title":"Diabetes Care"},{"key":"1132_CR165","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.2337\/db15-1690","volume":"65","author":"KA Patel","year":"2016","unstructured":"Patel, K. A. et al. Type 1 diabetes genetic risk score: a novel tool to discriminate monogenic and type 1 diabetes. Diabetes 65, 2094\u20132099 (2016).","journal-title":"Diabetes"},{"key":"1132_CR166","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.2337\/dc20-2872","volume":"45","author":"RA Oram","year":"2022","unstructured":"Oram, R. A. et al. Utility of diabetes type-specific genetic risk scores for the classification of diabetes type among multiethnic youth. Diabetes Care 45, 1124\u20131131 (2022).","journal-title":"Diabetes Care"},{"key":"1132_CR167","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s41591-022-01767-6","volume":"28","author":"L Hao","year":"2022","unstructured":"Hao, L. et al. Development of a clinical polygenic risk score assay and reporting workflow. Nat. Med. 28, 1006\u20131013 (2022).","journal-title":"Nat. Med."},{"key":"1132_CR168","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41591-024-02796-z","volume":"30","author":"NJ Lennon","year":"2024","unstructured":"Lennon, N. J. et al. Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations. Nat. Med. 30, 480\u2013487 (2024).","journal-title":"Nat. Med."},{"key":"1132_CR169","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/bmj.318.7185.698","volume":"318","author":"MJ Redondo","year":"1999","unstructured":"Redondo, M. J. et al. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study. BMJ 318, 698\u2013702 (1999).","journal-title":"BMJ"},{"key":"1132_CR170","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00125-022-05799-y","volume":"66","author":"K Ng","year":"2023","unstructured":"Ng, K. et al. Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children. Diabetologia 66, 93\u2013104 (2023).","journal-title":"Diabetologia"},{"key":"1132_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105144","volume":"104","author":"A Lind","year":"2024","unstructured":"Lind, A. et al. Childhood screening for type 1 diabetes comparing automated multiplex antibody detection by agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assays. eBioMedicine 104, 105144 (2024).","journal-title":"eBioMedicine"},{"key":"1132_CR172","doi-asserted-by":"publisher","first-page":"610","DOI":"10.2337\/dbi20-0054","volume":"71","author":"EK Sims","year":"2022","unstructured":"Sims, E. K. et al. Screening for type 1 diabetes in the general population: a status report and perspective. Diabetes 71, 610\u2013623 (2022).","journal-title":"Diabetes"},{"key":"1132_CR173","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01305-8","volume":"16","author":"KA Guertin","year":"2024","unstructured":"Guertin, K. A. et al. Implementation of type 1 diabetes genetic risk screening in children in diverse communities: the Virginia PrIMeD project. Genome Med. 16, 31 (2024).","journal-title":"Genome Med."},{"key":"1132_CR174","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41591-024-03438-0","volume":"31","author":"MB Cook","year":"2025","unstructured":"Cook, M. B. et al. Our Future Health: a unique global resource for discovery and translational research. Nat. Med. 31, 728\u2013730 (2025).","journal-title":"Nat. Med."},{"key":"1132_CR175","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15419","volume":"41","author":"KJ Bell","year":"2024","unstructured":"Bell, K. J. et al. Protocol for the Australian type 1 diabetes national screening pilot: assessing the feasibility and acceptability of three general population screening models in children. Diabet. Med. 41, e15419 (2024).","journal-title":"Diabet. Med."},{"key":"1132_CR176","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031586","volume":"9","author":"A Lynam","year":"2019","unstructured":"Lynam, A. et al. Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18\u201350 years. BMJ Open 9, e031586 (2019).","journal-title":"BMJ Open"},{"key":"1132_CR177","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.2337\/dc23-1815","volume":"47","author":"AG Jones","year":"2024","unstructured":"Jones, A. G. et al. Clinical prediction models combining routine clinical measures have high accuracy in identifying youth-onset type 2 diabetes defined by maintained endogenous insulin secretion: the SEARCH for diabetes in youth study. Diabetes Care 47, 2110\u20132119 (2024).","journal-title":"Diabetes Care"},{"key":"1132_CR178","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/s41591-020-0930-4","volume":"26","author":"LA Ferrat","year":"2020","unstructured":"Ferrat, L. A. et al. A combined risk score enhances prediction of type 1 diabetes among susceptible children. Nat. Med. 26, 1247\u20131255 (2020).","journal-title":"Nat. Med."},{"key":"1132_CR179","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc8980","volume":"13","author":"EK Sims","year":"2021","unstructured":"Sims, E. K. et al. Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals. Sci. Transl. Med. 13, eabc8980 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1132_CR180","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1902226","volume":"381","author":"KC Herold","year":"2019","unstructured":"Herold, K. C. et al. An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N. Engl. J. Med. 381, 603\u2013613 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1132_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101102","volume":"46","author":"MA Nauck","year":"2021","unstructured":"Nauck, M. A., Quast, D. R., Wefers, J. & Meier, J. J. GLP-1 receptor agonists in the treatment of type 2 diabetes \u2014 state-of-the-art. Mol. Metab. 46, 101102 (2021).","journal-title":"Mol. Metab."},{"key":"1132_CR182","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1161\/CIRCULATIONAHA.122.059595","volume":"146","author":"N Marx","year":"2022","unstructured":"Marx, N., Husain, M., Lehrke, M., Verma, S. & Sattar, N. GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes. Circulation 146, 1882\u20131894 (2022).","journal-title":"Circulation"},{"key":"1132_CR183","doi-asserted-by":"publisher","first-page":"e873","DOI":"10.1016\/S2589-7500(22)00174-1","volume":"4","author":"JM Dennis","year":"2022","unstructured":"Dennis, J. M. et al. Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study. Lancet Digit. Health 4, e873\u2013e883 (2022).","journal-title":"Lancet Digit. Health"},{"key":"1132_CR184","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1007\/s00125-021-05491-7","volume":"64","author":"J Tremblay","year":"2021","unstructured":"Tremblay, J. et al. Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control. Diabetologia 64, 2012\u20132025 (2021).","journal-title":"Diabetologia"},{"key":"1132_CR185","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002102","volume":"13","author":"JC Florez","year":"2016","unstructured":"Florez, J. C. Leveraging genetics to advance type 2 diabetes prevention. PLoS Med. 13, e1002102 (2016).","journal-title":"PLoS Med."},{"key":"1132_CR186","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2337\/dc18-0431","volume":"42","author":"AL Grubb","year":"2019","unstructured":"Grubb, A. L. et al. A type 1 diabetes genetic risk score can identify patients with GAD65 autoantibody-positive type 2 diabetes who rapidly progress to insulin therapy. Diabetes Care 42, 208\u2013214 (2019).","journal-title":"Diabetes Care"},{"key":"1132_CR187","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.2337\/dc18-0373","volume":"42","author":"KA Patel","year":"2019","unstructured":"Patel, K. A. et al. Zinc transporter 8 autoantibodies (ZnT8A) and a type 1 diabetes genetic risk score can exclude individuals with type 1 diabetes from inappropriate genetic testing for monogenic diabetes. Diabetes Care 42, e16\u2013e17 (2019).","journal-title":"Diabetes Care"},{"key":"1132_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2024.100523","volume":"4","author":"B Truong","year":"2024","unstructured":"Truong, B. et al. Integrative polygenic risk score improves the prediction accuracy of complex traits and diseases. Cell Genom. 4, 100523 (2024).","journal-title":"Cell Genom."},{"key":"1132_CR189","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56945-0","volume":"16","author":"A Misra","year":"2025","unstructured":"Misra, A. et al. Instability of high polygenic risk classification and mitigation by integrative scoring. Nat. Commun. 16, 1584 (2025).","journal-title":"Nat. Commun."},{"key":"1132_CR190","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin, A. R. et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet. 51, 584\u2013591 (2019).","journal-title":"Nat. Genet."},{"key":"1132_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2023.100408","volume":"3","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Polygenic prediction across populations is influenced by ancestry, genetic architecture, and methodology. Cell Genomics 3, 100408 (2023).","journal-title":"Cell Genomics"},{"key":"1132_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11112-0","volume":"10","author":"L Duncan","year":"2019","unstructured":"Duncan, L. et al. Analysis of polygenic risk score usage and performance in diverse human populations. Nat. Commun. 10, 3328 (2019).","journal-title":"Nat. Commun."},{"key":"1132_CR193","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1038\/s41588-024-01870-z","volume":"56","author":"K Yuan","year":"2024","unstructured":"Yuan, K. et al. Fine-mapping across diverse ancestries drives the discovery of putative causal variants underlying human complex traits and diseases. Nat. Genet. 56, 1841\u20131850 (2024).","journal-title":"Nat. Genet."},{"key":"1132_CR194","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41588-023-01394-y","volume":"55","author":"DO Martschenko","year":"2023","unstructured":"Martschenko, D. O., Wand, H., Young, J. L. & Wojcik, G. L. Including multiracial individuals is crucial for race, ethnicity and ancestry frameworks in genetics and genomics. Nat. Genet. 55, 895\u2013900 (2023).","journal-title":"Nat. Genet."},{"key":"1132_CR195","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41586-019-1310-4","volume":"570","author":"GL Wojcik","year":"2019","unstructured":"Wojcik, G. L. et al. Genetic analyses of diverse populations improves discovery for complex traits. Nature 570, 514\u2013518 (2019).","journal-title":"Nature"},{"key":"1132_CR196","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/s41556-021-00803-w","volume":"23","author":"R Horwitz","year":"2021","unstructured":"Horwitz, R., Riley, E. A. U., Millan, M. T. & Gunawardane, R. N. It\u2019s time to incorporate diversity into our basic science and disease models. Nat. Cell Biol. 23, 1213\u20131214 (2021).","journal-title":"Nat. Cell Biol."},{"key":"1132_CR197","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34940-z","volume":"13","author":"S Ghosh","year":"2022","unstructured":"Ghosh, S., Nehme, R. & Barrett, L. E. Greater genetic diversity is needed in human pluripotent stem cell models. Nat. Commun. 13, 7301 (2022).","journal-title":"Nat. Commun."},{"key":"1132_CR198","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.medj.2020.12.009","volume":"2","author":"L Woods-Burnham","year":"2021","unstructured":"Woods-Burnham, L. et al. The role of diverse populations in US clinical trials. Med 2, 21\u201324 (2021).","journal-title":"Med"},{"key":"1132_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2022.11.011","volume":"25","author":"MK Cho","year":"2023","unstructured":"Cho, M. K. et al. Words matter: the language of difference in human genetics. Genet. Med. 25, 100343 (2023).","journal-title":"Genet. Med."},{"key":"1132_CR200","unstructured":"National Academies of Sciences, Engineering, and Medicine. Using Population Descriptors in Genetics and Genomics Research: A New Framework for an Evolving Field (National Academies Press, 2023)."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01132-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01132-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01132-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:38:18Z","timestamp":1757187498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01132-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":200,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1132"],"URL":"https:\/\/doi.org\/10.1038\/s41574-025-01132-w","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"7 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.L.G. declares that her spouse holds stock options in Roche and is an employee of Genentech. M.S.U. is an unfunded collaborator with Nightingale and AstraZeneca. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}